Ironwood Pharmaceuticals (IRWD) News Today $0.77 -0.02 (-2.95%) Closing price 04:00 PM EasternExtended Trading$0.77 0.00 (-0.20%) As of 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IRWD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Vanguard Group Inc. Expands Stake in Ironwood PharmaceuticalsJuly 10, 2025 | gurufocus.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Hold" by BrokeragesJune 25, 2025 | marketbeat.com426,138 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Acquired by Universal Beteiligungs und Servicegesellschaft mbHJune 3, 2025 | marketbeat.comZacks Research Issues Pessimistic Estimate for IRWD EarningsJune 2, 2025 | marketbeat.comZacks Research Issues Optimistic Outlook for IRWD EarningsMay 31, 2025 | marketbeat.comMan Group plc Has $1.57 Million Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)May 26, 2025 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Bought by Deutsche Bank AGMay 20, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Reduces Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)May 15, 2025 | marketbeat.comLeerink Partnrs Has Bullish Outlook for IRWD Q2 EarningsMay 13, 2025 | marketbeat.comPacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc.May 8, 2025 | gurufocus.comPacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc.May 8, 2025 | gurufocus.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Recommendation of "Hold" by BrokeragesMay 8, 2025 | marketbeat.comIronwood Pharmaceuticals Reports First Quarter 2025 ResultsMay 7, 2025 | businesswire.comZacks Research Analysts Boost Earnings Estimates for IRWDMay 6, 2025 | marketbeat.comZacks Research Brokers Increase Earnings Estimates for IRWDMay 4, 2025 | marketbeat.comIronwood Pharmaceuticals (IRWD) Expected to Announce Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comIronwood Pharmaceuticals to Participate in The Citizens Life Sciences ConferenceApril 30, 2025 | businesswire.comIronwood Raises 2025 Adj. EBITDA OutlookApril 26, 2025 | nasdaq.comIronwood backs FY25 revenue view $260M-$290M, consensus $287.07MApril 26, 2025 | markets.businessinsider.comIronwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025April 25, 2025 | gurufocus.comIronwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares riseApril 25, 2025 | msn.comIronwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock NewsApril 25, 2025 | gurufocus.comIronwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA GuidanceApril 25, 2025 | businesswire.comIronwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral SupportApril 22, 2025 | businesswire.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Down 30.8% in MarchApril 20, 2025 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Lowered by Craig HallumApril 20, 2025 | marketbeat.comLeerink Partnrs Has Strong Forecast for IRWD Q2 EarningsApril 19, 2025 | marketbeat.comResearch Analysts Offer Predictions for IRWD Q3 EarningsApril 18, 2025 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Downgraded by StockNews.com to "Hold"April 17, 2025 | marketbeat.comIronwood Pharmaceuticals' (IRWD) "Equal Weight" Rating Reaffirmed at Wells Fargo & CompanyApril 17, 2025 | marketbeat.comJefferies Financial Group Reaffirms "Hold" Rating for Ironwood Pharmaceuticals (NASDAQ:IRWD)April 17, 2025 | marketbeat.comIronwood Pharma (IRWD) was downgraded to a Hold Rating at Craig-HallumApril 17, 2025 | markets.businessinsider.comLeerink Partners Has Lowered Expectations for Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock PriceApril 16, 2025 | marketbeat.comIronwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD ...April 16, 2025 | gurufocus.comIronwood Pharmaceuticals (IRWD) Faces Setback After FDA RequestApril 16, 2025 | gurufocus.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Lowered by Citizens JmpApril 16, 2025 | marketbeat.comIronwood Pharma Provides Update On Apraglutide; Plans Strategic AlternativesApril 15, 2025 | nasdaq.comIronwood downgraded to Hold from Buy at JefferiesApril 15, 2025 | markets.businessinsider.comWells Fargo Downgrades Ironwood Pharmaceuticals (IRWD)April 15, 2025 | msn.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by LSV Asset ManagementApril 15, 2025 | marketbeat.comIronwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal DrugApril 14, 2025 | benzinga.comIronwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal DrugApril 14, 2025 | benzinga.comIronwood Pharmaceuticals stock tumbles after FDA requires additional trialApril 14, 2025 | au.investing.comIronwood looks for strategic options after regulatory hurdle for lead drugApril 14, 2025 | msn.comIronwood Pharmaceuticals (IRWD) Considers Strategic Options After FDA SetbackApril 14, 2025 | gurufocus.comIronwood Pharmaceuticals Provides Clinical and Regulatory Update on ApraglutideApril 14, 2025 | gurufocus.comIronwood Pharmaceuticals Provides Clinical and Regulatory Update on ApraglutideApril 14, 2025 | finance.yahoo.comIronwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide | IRWD Stock NewsApril 14, 2025 | gurufocus.comRenaissance Technologies LLC Acquires 469,043 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)April 13, 2025 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Moderate Buy" by BrokeragesApril 13, 2025 | marketbeat.com Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address IRWD Media Mentions By Week IRWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼1.150.96▲Average Medical News Sentiment IRWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼04▲IRWD Articles Average Week Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AbbVie News Lexicon Pharmaceuticals News Emergent Biosolutions News Rigel Pharmaceuticals News XOMA Royalty News Vanda Pharmaceuticals News Verastem News Codexis News Crescent Biopharma News Agenus News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRWD) was last updated on 7/18/2025 by MarketBeat.com Staff From Our Partners[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredWhen your faith is put to the test, what will you do?Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
